Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -1.94% inched 0.01% higher to $167.58 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.02% falling 0.72% to 4,274.04 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.15% falling 0.50% to 33,980.32. This was the stock's third consecutive day of gains. Johnson & Johnson closed $19.11 below its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +4.49% fell 0.70% to $325.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -1.07% rose 0.50% to $91.04, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -2.29% fell 1.18% to $49.27. Trading volume (7.4 M) eclipsed its 50-day average volume of 6.8 M.